[30M] 4 Months of Progress Oral 3MgMin&1.1MgFin + .5mm Derma Roller Mondays and Fridays Progress Pictures 6/26/2024
A user shared their 4-month progress using oral Minoxidil (3mg) and Finasteride (1.1mg) with a 0.5mm derma roller twice a week, noting visible improvement. Others congratulated and encouraged them to continue the treatment.
View this post in the Community →
Similar Community Posts Join
5 / 5 resultscommunity What's the strongest and nuclear yet safe Hair Recovery stack?
The conversation discusses various hair recovery treatments, including finasteride, dutasteride, minoxidil, RU58841, ketoconazole shampoo, microneedling, and tretinoin. Users debate the effectiveness and safety of these treatments, with some suggesting combinations like dutasteride and minoxidil as potent options.
community Finasteride gyno experience and in dire need of advice
A user experienced puffy nipples and lumps from finasteride, leading to a dilemma between continuing treatment with potential surgery or accepting hair loss. They restarted finasteride at a lower dose with supplements but still face side effects and are seeking advice on whether to persist or stop.
community 22M, 6 months progress. No finasteride, no oral meds. Topical only.
A 22-year-old shared their 6-month hair loss progress using only topical treatments like minoxidil, derma rolling, and red light therapy, without finasteride or oral medications. Other users suggested adding DHT blockers like RU58841 and ketoconazole shampoo for better results.
community I’m on a crazy hairloss stack and I’m still losing hair and not experiencing any regrowth. What is going on?
The user is using a combination of hair loss treatments including finasteride, stemoxydine, oral minoxidil, RU58841, dermastamping, ketoconazole shampoo, collagen, Viviscal, and biotin, and has improved their diet. Despite these efforts, they are still experiencing hair shedding and scalp itchiness, and are considering increasing their minoxidil dosage or starting dutasteride.
community 15 months total on Dut/Min/RU and microneedling 1mm every other week
The user reported significant hair improvement over 15 months using dutasteride, minoxidil (oral and topical), RU58841, ketoconazole, and microneedling. They are considering a hair transplant in 4-6 months.
Related Research
6 / 6 resultsresearch Experimental and early investigational drugs for androgenetic alopecia
This review discusses current and emerging therapeutic strategies for androgenetic alopecia, noting limited evidence but suggesting areas such as prostaglandin analogs, PRP, and progenitor cell therapies as promising future directions.
research Topical ketoconazole: a systematic review of current dermatological applications and future developments
This review found topical ketoconazole to be highly effective against Malassezia-related skin conditions, though other treatments may outperform it for Tinea and Candida infections.
research Treatments for Androgenetic Alopecia and Alopecia Areata
This review discusses current and emerging drug therapies for treating androgenetic alopecia and alopecia areata, and reports no clinical results; it highlights a need for improved and novel treatments.
research Androgenetische Alopezie beim Mann . Male androgenetic alopecia
Male androgenetic alopecia involves hair follicle miniaturization due to DHT, with potential treatments using inhibitors and blockers.
research Comparative Evaluation of the Clinical Efficacy of PRP-Therapy, Minoxidil, and Their Combination with Immunohistochemical Study of the Dynamics of Cell Proliferation in the Treatment of Men with Androgenetic Alopecia
This study found that combining platelet-rich plasma therapy with minoxidil was more effective in treating androgenetic alopecia in men than either treatment alone.
research Recent advances in microneedle composites for biomedical applications: Advanced drug delivery technologies
This review outlines the development, applications, and challenges of microneedle-based drug delivery from 2000-2019, particularly highlighting fabrication techniques, but reports no new clinical results.